A study comparing individuals with persistent depressive disorder to those with episodic major depressive disorder found that those with persistent depression had lower treatment expectations. These ...

"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, ...

A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of ...

Major depressive disorder is linked to Th2 immune dysregulation similar to atopic dermatitis. Could dupilumab offer a new therapy? Read more.

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...

Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

Major depressive disorder is a debilitating condition that impacts around 5% of adults worldwide. While doctors commonly prescribe antidepressants to patients, it has several side effects and might ...

Mental health professionals use the DSM to standardize the diagnosis and treatment processes for mental health conditions, including types of depression. The Diagnostic and Statistical Manual of ...